BeOne Medicines AG Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	244,681	235,145	143,553	133,746	157,552	176,878
Market Cap Growth	41.85%	63.80%	7.33%	-15.11%	-10.93%	15.32%
Enterprise Value	220,117	214,043	131,421	116,580	127,415	156,439
Last Close Price	257.70	268.60	161.02	139.04	132.45	144.51
PE Ratio	121.92	117.17	-	-	-	-
PS Ratio	6.55	6.29	5.16	7.67	16.13	23.67
PB Ratio	8.02	7.71	5.90	5.33	5.21	4.54
P/TBV Ratio	8.02	7.71	5.99	5.42	5.26	4.58
P/FCF Ratio	-	29.82	-	-	-	-
P/OCF Ratio	31.02	29.82	-	-	-	-
EV/Sales Ratio	6.02	5.73	4.72	6.69	13.05	20.94
EV/EBITDA Ratio	55.78	53.06	-	-	-	-
EV/EBIT Ratio	71.96	68.44	-	-	-	-
EV/FCF Ratio	-	27.14	-	-	-	-
Debt / Equity Ratio	0.23	0.23	0.32	0.26	0.14	0.11
Debt / EBITDA Ratio	1.77	1.77	-	-	-	-
Debt / FCF Ratio	0.90	0.90	-	-	-	-
Net Debt / Equity Ratio	-0.82	-0.82	-0.46	-0.63	-0.90	-0.97
Net Debt / EBITDA Ratio	-6.22	-6.22	3.85	1.99	2.28	4.25
Net Debt / FCF Ratio	-3.18	-3.18	2.44	1.30	2.16	3.80
Asset Turnover	0.76	0.76	0.65	0.40	0.19	0.17
Inventory Turnover	1.21	1.21	1.30	1.09	1.09	0.99
Quick Ratio	3.31	3.31	1.51	1.97	3.22	4.45
Current Ratio	3.68	3.68	1.80	2.32	3.55	4.76
Return on Equity (ROE)	7.46%	7.46%	-18.77%	-22.26%	-38.11%	-29.15%
Return on Assets (ROA)	3.96%	3.96%	-6.07%	-12.40%	-15.00%	-12.72%
Return on Invested Capital (ROIC)	32.69%	24.09%	-36.94%	-138.84%	-549.14%	-
Return on Capital Employed (ROCE)	6.80%	6.80%	-15.40%	-30.30%	-36.40%	-20.70%
Earnings Yield	0.82%	0.85%	-3.28%	-4.67%	-8.77%	-5.24%
FCF Yield	-	3.35%	-3.22%	-9.12%	-7.98%	-5.61%
Buyback Yield / Dilution	-7.75%	-7.75%	-0.86%	-1.22%	-11.15%	-11.16%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.